224 related articles for article (PubMed ID: 19706228)
1. Effect of quality of life impact and clinical severity on adherence to topical acne treatment.
Tan JK; Balagurusamy M; Fung K; Gupta AK; Thomas DR; Sapra S; Lynde C; Poulin Y; Gulliver W; Sebaldt RJ
J Cutan Med Surg; 2009; 13(4):204-8. PubMed ID: 19706228
[TBL] [Abstract][Full Text] [Related]
2. Effects of skin care and makeup under instructions from dermatologists on the quality of life of female patients with acne vulgaris.
Matsuoka Y; Yoneda K; Sadahira C; Katsuura J; Moriue T; Kubota Y
J Dermatol; 2006 Nov; 33(11):745-52. PubMed ID: 17073988
[TBL] [Abstract][Full Text] [Related]
3. Effect of adapalene 0.1%/benzoyl peroxide 2.5% topical gel on quality of life and treatment adherence during long-term application in patients with predominantly moderate acne with or without concomitant medication - additional results from the non-interventional cohort study ELANG.
Gollnick HP; Friedrich M; Peschen M; Pettker R; Pier A; Streit V; Jöstingmeyer P; Porombka D; Rojo Pulido I; Jäckel A
J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 4():23-9. PubMed ID: 26059731
[TBL] [Abstract][Full Text] [Related]
4. Creation of a tool to assess adherence to treatments for acne.
Pawin H; Beylot C; Chivot M; Faure M; Poli F; Revuz J; Dréno B
Dermatology; 2009; 218(1):26-32. PubMed ID: 18946201
[TBL] [Abstract][Full Text] [Related]
5. Divergence of demographic factors associated with clinical severity compared with quality of life impact in acne.
Tan JK; Li Y; Fung K; Gupta AK; Thomas DR; Sapra S; Lynde C; Poulin Y; Gulliver W; Sebaldt RJ
J Cutan Med Surg; 2008; 12(5):235-42. PubMed ID: 18845093
[TBL] [Abstract][Full Text] [Related]
6. Tazarotene foam, 0.1%, for the treatment of acne.
Smith JA; Narahari S; Hill D; Feldman SR
Expert Opin Drug Saf; 2016 Jan; 15(1):99-103. PubMed ID: 26560170
[TBL] [Abstract][Full Text] [Related]
7. Adherence to drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: the ACTUO observational prospective multicenter cohort trial in 643 patients.
de Lucas R; Moreno-Arias G; Perez-López M; Vera-Casaño Á; Aladren S; Milani M;
BMC Dermatol; 2015 Sep; 15():17. PubMed ID: 26361978
[TBL] [Abstract][Full Text] [Related]
8. Pilot randomized-control trial to assess the effect product sampling has on adherence using adapalene/benzoyl peroxide gel in acne patients.
Sandoval LF; Semble A; Gustafson CJ; Huang KE; Levender MM; Feldman SR
J Drugs Dermatol; 2014 Feb; 13(2):135-40. PubMed ID: 24509962
[TBL] [Abstract][Full Text] [Related]
9. Practical considerations in acne treatment and the clinical impact of topical combination therapy.
Krakowski AC; Stendardo S; Eichenfield LF
Pediatr Dermatol; 2008 Jun; 25 Suppl 1():1-14. PubMed ID: 18494684
[TBL] [Abstract][Full Text] [Related]
10. Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris.
Webster G; Thiboutot DM; Chen DM; Merikle E
Cutis; 2010 Nov; 86(5):263-7. PubMed ID: 21214129
[TBL] [Abstract][Full Text] [Related]
11. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
[TBL] [Abstract][Full Text] [Related]
12. Azelaic acid 20 % cream: effects on quality of life and disease severity in adult female acne patients.
Kainz JT; Berghammer G; Auer-Grumbach P; Lackner V; Perl-Convalexius S; Popa R; Wolfesberger B
J Dtsch Dermatol Ges; 2016 Dec; 14(12):1249-1259. PubMed ID: 27897372
[TBL] [Abstract][Full Text] [Related]
13. The noncompliant patient with acne.
Tanghetti EA
Skin Therapy Lett; 2011; 16(10):4-5. PubMed ID: 22337078
[TBL] [Abstract][Full Text] [Related]
14. Acne management in Japan: study of patient adherence.
Miyachi Y; Hayashi N; Furukawa F; Akamatsu H; Matsunaga K; Watanabe S; Kawashima M
Dermatology; 2011; 223(2):174-81. PubMed ID: 22025005
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of topical antimicrobials in treatment of acne vulgaris.
Bartlett KB; Davis SA; Feldman SR
J Drugs Dermatol; 2014 Jun; 13(6):658-62. PubMed ID: 24918554
[TBL] [Abstract][Full Text] [Related]
16. Frequency of Primary Nonadherence to Acne Treatment.
Anderson KL; Dothard EH; Huang KE; Feldman SR
JAMA Dermatol; 2015 Jun; 151(6):623-6. PubMed ID: 25793290
[TBL] [Abstract][Full Text] [Related]
17. Medical adherence to acne therapy: a systematic review.
Snyder S; Crandell I; Davis SA; Feldman SR
Am J Clin Dermatol; 2014 Apr; 15(2):87-94. PubMed ID: 24481999
[TBL] [Abstract][Full Text] [Related]
18. Subject preferences for acne treatments containing adapalene gel 0.1%: results of the MORE trial.
Cook-Bolden F
Cutis; 2006 Jul; 78(1 Suppl):26-33. PubMed ID: 16910028
[TBL] [Abstract][Full Text] [Related]
19. How patients experience and manage dryness and irritation from acne treatment.
Feldman SR; Chen DM
J Drugs Dermatol; 2011 Jun; 10(6):605-8. PubMed ID: 21637901
[TBL] [Abstract][Full Text] [Related]
20. Severity of acne and its impact on quality of life.
Zaraa I; Belghith I; Ben Alaya N; Trojjet S; Mokni M; Ben Osman A
Skinmed; 2013; 11(3):148-53. PubMed ID: 23930353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
